Our steady, but careful growth over the past 3 years has resulted in a company teeming with talent. With our expanded team, we are able to continue to deliver on a growing list of projects for our biopharma and medtech clients globally. From connected combination products, such as auto-injector pens for diabetes, to a dosing calculator to treat Hemophilia A, to patient engagement apps for people with rare and serious diseases, BrightInsight’s team growth has enabled us to support more and more transformational solutions across therapeutic areas.
At our core, we value partnership. We are strategic partners to our customers, and we partner together every day to achieve our vision of transforming patient outcomes globally by bringing the power of digital technology to healthcare.
Our shared values are what motivate us and what help us to work seamlessly together. As we continue to grow the BrightInsight team beyond our 100 employees, our collective commitment to our values bonds everyone together.
I want to take a moment to recognize our 100 employees and express my gratitude to each and every one of you.
I am inspired by the passion and relentless perseverance you display each day. Whether it’s your passion for BrightInsight’s vision, your commitment to excellence when delivering for customers, or your competitive spirit in our global employee fitness challenge, you bring amazing energy to everything you do.
Even amidst the new challenges that COVID-19 presents, our team shows up. We have many employees – myself included – who are working from home while helping our children with distance learning, yet despite new chaos or responsibilities you are executing on projects, helping us hit new milestones and supporting one another.
I am regularly humbled by the talent and experience of our team. It’s rare – and quite challenging – to grow at the rate we are growing while maintaining our unique culture and not lowering the bar for talent.
I couldn't imagine a better team to execute for our customers, to deliver for patients globally, and to cement our position as the de-facto regulated digital health platform for biopharma and medtech.